- 501 Orchard Road, #04-08 Wheelock Place, Singapore 238880
- (65) 6235 4429
- hello@vidaskinclinic.com
- (65) 9830 0597
Low-dose preventative treatment refers to the use of lower-than-standard doses, the same active ingredient used in conventional wrinkle-relaxing injections, typically offered to younger patients who are starting to notice early expression lines rather than established, deeply set wrinkles. The idea is not a different product, but a different dose and a different stage of intervention.
Interest in starting treatment earlier, sometimes called prejuvenation, has grown alongside broader interest in preventing visible signs of ageing rather than only treating them once they’ve appeared. It’s worth understanding what this approach can realistically offer, and where the evidence is more established than in others.
Low-dose preventative treatment uses the same active ingredient as standard treatment, working through the same mechanism of blocking acetylcholine release at the neuromuscular junction to relax targeted muscles. The difference is quantity: lower unit counts are used at the same standard injection sites, such as the glabella, forehead and crow’s feet, aiming for a lighter, more partial reduction in muscle movement rather than full relaxation.
Standard-dose treatment is generally used to substantially reduce movement in a targeted muscle, which is appropriate for more established lines. Low-dose treatment aims to soften muscle activity just enough to reduce the repetitive creasing that contributes to lines forming, while preserving more visible expression. This is a dosing decision made by your clinician based on your current lines, muscle strength, and goals, not a separate product.
Wrinkles that appear only when you make an expression, dynamic lines, are driven by the underlying muscle. Over years of repeated contraction, the skin above these muscles can develop a crease that eventually remains visible even at rest, becoming a static line. This is a well-established mechanism in the ageing literature, alongside collagen loss and sun exposure, which also contribute independently to static wrinkle formation.
The theoretical rationale for early, low-dose treatment is that reducing repetitive muscle contraction earlier may slow how quickly a dynamic line becomes a permanent static one. This mechanism is biologically plausible and consistent with how static wrinkles are understood to form. However, long-term comparative studies specifically measuring whether early low-dose treatment delays static wrinkle formation, compared with starting treatment later, are more limited than the well-established evidence for treating existing lines. Patients considering this approach should understand the distinction between a plausible rationale and firmly established long-term outcome data.
Patients in their mid-twenties to thirties who notice lines appearing during expression, particularly with strong or frequent facial movement, sometimes consider low-dose treatment as an early intervention rather than waiting until lines are visible at rest.
A family history of deep-set expression lines, thinner skin, or skin that shows creasing easily are sometimes factors patients and their clinician discuss when considering whether earlier, lower-dose treatment is a reasonable option, alongside broader skincare and sun protection habits.
Because lower doses are used, results are generally more subtle than standard-dose treatment, with more visible remaining expression. This is often the goal for patients who want a softened appearance without a noticeably “treated” look.
Low-dose treatment cannot reverse existing static lines, restore lost volume, or replace sun protection and good skincare habits, which remain the most evidence-based tools for reducing premature skin ageing. It is one component of a broader approach to skin health, not a substitute for it.
Because lower doses tend to wear off somewhat faster than standard dosing, some patients find they need slightly more frequent treatment, often every three to four months, to maintain a consistent effect, though this varies individually.
The safety profile of low-dose preventative treatment is the same as standard-dose treatment, since it is the same active ingredient at a lower dose. Standard contraindications apply, including pregnancy and breastfeeding, certain neuromuscular conditions, and specific medications. A full medical history and realistic discussion of goals is an important first step, particularly for patients who have never had the treatment before.
Deciding whether to start wrinkle-relaxing treatment earlier is a personal choice that depends on your skin, your expression patterns, and your goals, not a decision with a single right answer for everyone.
At VIDASKIN, low-dose preventative treatment is planned around an honest assessment of your current skin and muscle activity, using conservative, individually tailored dosing to support a natural, undertreated look rather than a fixed protocol applied to every patient.
To learn more or book a consultation, visit or contact us today.
Dr. Kay Low is a UK-trained medical doctor with over 7 years of clinical experience across the UK and Singapore, specialising in aesthetic medicine. A graduate of the University of Cambridge, she has worked across multiple medical and surgical disciplines in the UK and Singapore before completing postgraduate training in Family Medicine and advanced training in aesthetic medicine.
